Patent 7930287
PTAB challenges
AIA trial proceedings at the USPTO Patent Trial and Appeal Board — IPR, PGR, and CBM. Petitioners, judge panels, claim-level invalidation outcomes from Final Written Decisions, and Federal Circuit appeals. The single most important defensive datapoint after litigation history.
Active provider: Google · gemini-2.5-flash
Proceedings on file (0)
All PTAB activity →AIA trial proceedings (IPR / PGR / CBM) filed at the USPTO Patent Trial and Appeal Board against this patent. Sourced from the USPTO Open Data Portal and refreshed every six hours; each proceeding number deep-links to the PTAB E2E docket.
Current assignee: Health Care Service Corp
No PTAB proceedings on file. This patent has not been challenged via IPR, PGR, or CBM. The absence is itself a signal — well-asserted patents eventually attract IPRs. The LLM analysis below may surface filings the ODP feed hasn’t indexed yet.
PTAB challenges
AIA trial proceedings at the USPTO Patent Trial and Appeal Board — IPR, PGR, and CBM. Petitioners, judge panels, claim-level invalidation outcomes from Final Written Decisions, and Federal Circuit appeals. The single most important defensive datapoint after litigation history.
Proceedings overview
There are no AIA trial proceedings (Inter Partes Review, Post-Grant Review, or Covered Business Method review) on file for US Patent 7930287 as of the most recent data ingest. This indicates the patent has not been subjected to PTAB challenges, meaning all claims remain untested by this specific administrative process.
Strategic summary
As no PTAB proceedings have been filed against US Patent 7930287, all 31 claims of the patent (Claims 1-31) remain UNTESTED by the PTAB. There are no claims that have been canceled or sustained through IPR, PGR, or CBM trials.
The absence of PTAB proceedings means there is currently no estoppel landscape under 35 U.S.C. § 315(e)(2) for this patent. A defendant facing assertion of this patent today would generally have all prior art grounds available for potential PTAB challenge, assuming they meet the statutory requirements for filing such a petition. There are no patterns of repeated petitions by the same entity, aggressive appeals by the patent owner, or involvement by defensive aggregators like Unified Patents to report via PTAB activity.
Recommended next steps
Since no PTAB activity exists for US7930287, a potential defendant has several options:
- Consider filing an IPR: If facing assertion of this patent, evaluating the claims against prior art to determine the viability of an Inter Partes Review petition could be a strong defensive strategy. This would provide an opportunity to challenge the patentability of the claims before the PTAB.
- Prior Art Search: Conduct a thorough prior art search, focusing on the patent's priority date of March 14, 2008, to identify potential grounds for invalidity under 35 U.S.C. §§ 102 and 103, which would be essential for an IPR.
- Monitor PTAB Filings: Continuously monitor the PTAB's E2E system for any newly filed petitions related to US7930287, as the landscape can change rapidly.
Generated 6/1/2026, 12:48:32 AM